Gene expression of PTGIR and PTGER4 in hiPSC monocyte/macrophages derived. by Mohamad Karaky (8910497)

Subjects:

The impact of PTGIR agonist on CP genes at different time. by Mohamad Karaky (8910497)

Subjects:

A. The difference in mean value of AT1 measured preoperative, after lenticule creation, and after lenticule extraction during SMILE. by Yang Shen (66591)

Vasodilator capacity to decrease maximal hypoxic mPAP and AUC_SaO2. by Eva Maria Becker (451197)

“…<p>Vasodilator capacity to decrease maximal hypoxic mPAP (positive treatment effect) and AUC_SaO2 (unwanted desaturation effect) based on (A) pooled effects at all dose levels tested (N = 6, four doses per group) and (B) at each drug's maximal effective dose (i.e., cumulative dose) (mean ± SEM, N = 6, doses as indicated). …”

Table_1_Atypical neurological manifestations in anti-IgLON5 disease: a case report.docx by Yun Chen (279569)

“…<p>Anti-IgLON5 disease is a recently discovered autoimmune encephalopathy with sleep disorder as a hallmark in the majority of reported cases. …”

ApoA-I and HDL-3 inhibit leukocyte adhesion to endothelial cells in vitro via a PKC-mediated signaling pathway. by Scott J. Cameron (838315)

Semi-log plot of the number of cities in IT provinces, <i>N</i>_{<i>c</i>,<i>p</i>}; the provinces are ranked according to their decreasing “order of importance”, for vario... by Marcel Ausloos (748325)

Mesenchymal Stem Cells Promote Mammosphere Formation and Decrease E-Cadherin in Normal and Malignant Breast Cells by Ann H. Klopp (243729)

“…</p><h3>Conclusions</h3><p>MSC increase the efficiency of primary mammosphere formation in normal and malignant breast cells and decrease E-cadherin expression, a biologic event associated with breast cancer progression and resistance to therapy.…”

Changes in growth characteristics (A = shoot length; B = root length; C = collar diameter; D = number of leaves) of M. stenopetala under drought conditions. by Nadia Khater (22553166)

S1 Graphical abstract - by Yu Xiong (1478806)

Risk of bias graph. by Yu Xiong (1478806)

Fig 1 - by Yu Xiong (1478806)

Fig 3 - by Yu Xiong (1478806)

Forest plots describing ORs of the association between low baseline PNI and OS at 1-year(A), 3-year(B), 5-year(C), 8-year(D) and 10-year(E) in breast cancer patients. by Guoming Hu (4377886)

Forest plots describing ORs of the association between reduced baseline PNI and DFS at 1-year (A), 3-year(B), 5-year(C), 8-year(D) and 10-year(E) in breast cancer patients. by Guoming Hu (4377886)

Serum VEGF-D levels are elevated at baseline, decrease with sirolimus treatment, and correlate with kidney angiomyolipoma size. by Sandra L. Dabora (206838)

“…According to other studies <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0023379#pone.0023379-Glasgow1" target="_blank">[39]</a>, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0023379#pone.0023379-Young1" target="_blank">[41]</a>, mean serum VEGF-D levels in control female populations are 300–657 ng/ml (indicated by gray box, see additional details in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0023379#pone.0023379.s013" target="_blank">Table S4</a>, mean VEGF-D levels in control males is not available). …”

<i>vFlip</i> expression largely protects from lethality induced by <i>cFlip</i> deletion. by Barbara Ruder (8379354)

ULK1 is a substrate of CDK1/cyclin B in mitosis. by Zhiyuan Li (205620)

Effects of clonal integration and <i>Bacillus subtilis</i> on ramet number (A, E, I), total stolon length (B, F, J), specific stolon length (C, G, K), and root-shoot ratio (D, H, L... by Bing-Nan Zhao (21553401)

Compound C treatment decreases hTERT promoter activity, but AMPK activators do not increase the activity. by Daum Jo (6009578)